Who Owns SXTC?
China SXT Pharmaceuticals, Inc. — Institutional Ownership & 13F Holdings
$1.42
-0.06 (-4.03%)
Market Cap
$1.8M
Shares Outstanding
—
Institutional Holders
2
Total Inst. Value
$13K
% of Float Held
—
QoQ Holder Change
-1
Institutional data as of Q1 2025
New Positions
2
Closed Positions
0
Increased
0
Decreased
0
Institutional Ownership Trend
Top 10 Institutional Holders(Q1 2025)
| # | Fund | Value | Shares |
|---|---|---|---|
| 1 | UBS Group AGNew | $13K | 5,270 |
| 2 | ACADIAN ASSET MANAGEMENT LLCNew | $0 | 48 |
Biggest Buyers & Sellers This Quarter
Top Buyers
| Fund | Shares Added | Value |
|---|---|---|
| UBS Group AGNew | +5K | $13K |
| ACADIAN ASSET MANAGEMENT LLCNew | +48 | $0 |
Top Sellers
| Fund | Shares Removed | Value |
|---|
Related Stocks
Frequently Asked Questions
How many institutional investors hold SXTC?
As of Q1 2025, 2 institutional investors report holding SXTC (China SXT Pharmaceuticals, Inc.) in their 13F filings.
Which hedge fund owns the most SXTC?
The largest institutional holder of SXTC is UBS Group AG with $13K in shares.
Are institutions buying or selling SXTC?
This quarter, 2 institutions opened new positions in SXTC and 0 closed their positions.
What is 13F institutional ownership?
SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.
How often is institutional ownership data updated?
13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.